NCCN Backs Avastin for Breast Cancer

posted on Jul 27 by in the Uncategorized category (MedPage Today) -- The future of bevacizumab (Avastin) as a breast cancer therapy took another turn when the National Comprehensive Cancer Network, a major organization of cancer specialists, voted to continue its support for the indication.

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes